Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Neuroscience Letters
|
May 8, 2007
Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells
Catherine R McMillan, Rohita Sharma, Tom Ottenhof, et al.
Basic & Clinical Pharmacology & Toxicology
|
January 28, 2014
Induction of neurotrophic and differentiation factors in neural stem cells by valproic acid
Walaa Almutawaa, Na Hyea Kang, Yi Pan, et al.
Neuroscience Letters
|
June 10, 2014
Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer's disease
Sarra G Bahna, Arani Sathiyapalan, Jane A Foster, et al.
European Journal of Pharmacology
|
June 14, 2008
Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells
Bora Kim, Lyda M Rincón Castro, Sana Jawed, et al.
Brain Research
|
December 27, 2005
Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
Rohita Sharma, Catherine R McMillan, Catherine C Tenn, et al.
Molecular Biology Reports
|
May 16, 2020
5-Azacytidine upregulates melatonin MT<sub>1</sub> receptor expression in rat C6 glioma cells: oncostatic implications
Emily E Hartung, Sumeya Z Mukhtar, Syeda M Shah, et al.
The International Journal of Neuropsychopharmacology
|
January 17, 2012
Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain
Lennard P Niles, Arani Sathiyapalan, Sarra Bahna, et al.
Brain Research
|
October 4, 2016
Altered melatonin MT<sub>1</sub> receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundle
Na Hyea Kang, Candace H Carriere, Sarra G Bahna, et al.
European Journal of Pharmacology
|
February 17, 2007
Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation
Sana Jawed, Bora Kim, Thomas Ottenhof, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 23, 2012
HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation
Angie Yeung, Rishi K Bhargava, Raphael Ahn, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Neuroscience Letters
|
May 8, 2007
Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells
Catherine R McMillan, Rohita Sharma, Tom Ottenhof, et al.
Basic & Clinical Pharmacology & Toxicology
|
January 28, 2014
Induction of neurotrophic and differentiation factors in neural stem cells by valproic acid
Walaa Almutawaa, Na Hyea Kang, Yi Pan, et al.
Neuroscience Letters
|
June 10, 2014
Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer's disease
Sarra G Bahna, Arani Sathiyapalan, Jane A Foster, et al.
European Journal of Pharmacology
|
June 14, 2008
Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells
Bora Kim, Lyda M Rincón Castro, Sana Jawed, et al.
Brain Research
|
December 27, 2005
Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease
Rohita Sharma, Catherine R McMillan, Catherine C Tenn, et al.
Molecular Biology Reports
|
May 16, 2020
5-Azacytidine upregulates melatonin MT<sub>1</sub> receptor expression in rat C6 glioma cells: oncostatic implications
Emily E Hartung, Sumeya Z Mukhtar, Syeda M Shah, et al.
The International Journal of Neuropsychopharmacology
|
January 17, 2012
Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain
Lennard P Niles, Arani Sathiyapalan, Sarra Bahna, et al.
Brain Research
|
October 4, 2016
Altered melatonin MT<sub>1</sub> receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundle
Na Hyea Kang, Candace H Carriere, Sarra G Bahna, et al.
European Journal of Pharmacology
|
February 17, 2007
Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation
Sana Jawed, Bora Kim, Thomas Ottenhof, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 23, 2012
HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation
Angie Yeung, Rishi K Bhargava, Raphael Ahn, et al.
Page
of 3